IAM dilution watch: offerings and filings
IAM (Iambic Therapeutics, Inc.) filed a new prospectus supplement (424B) on Thursday, October 15, 2026 (S-1). Below is every offering event for the name in the last 60 days, newest first, and its Momo Meter alert history: 16 alerts in 90 days, last Oct 16, 3:50 PM.
| Date | Event | Momo Meter alerts, 90 days |
|---|---|---|
| Oct 15, 2026 | New 424B filed a new prospectus supplement (424B), S-1, ipo | 16 last Oct 16, 3:50 PM |
| Oct 15, 2026 | Priced priced an offering, S-1, ipo | 16 last Oct 16, 3:50 PM |
| Oct 14, 2026 | Effective registration went effective, S-1, ipo | 16 last Oct 16, 3:50 PM |
| Sep 21, 2026 | New filing filed a new registration, S-1, ipo | 16 last Oct 16, 3:50 PM |
A registration (S-1 or S-3) is permission to sell new shares later; effective means the SEC cleared it; a pricing or a 424B supplement means shares are being sold now; an MEF adds shares to a sale in progress. New shares sold into the market dilute existing holders.